Clinical Trials
27
3 active
Approvals
0
Total approvals
Agencies
0
Regulatory bodies
Founded
1963
Completed
12
44.4%
Enrolling By Invitation
1
3.7%
Not yet recruiting
2
7.4%
Recruiting
1
3.7%
Terminated
6
22.2%
Unknown
2
7.4%
Withdrawn
3
11.1%
No approval data available
- Pseudomonas aeruginosa accounts for approximately 4% of UTI cases in the Gulf Coast region, nearly double the national average, according to new research published in mSphere. - Researchers identified numerous previously unknown genetic strains of P. aeruginosa, with one strain linked to catheter use and another associated with diabetes. - Nearly one-third of bacterial isolates showed resistance to levofloxacin, and several strains exhibited multidrug resistance, complicating treatment options. - The study highlights substantial uncharacterized diversity among urinary P. aeruginosa isolates and calls for larger epidemiological studies to understand regional prevalence patterns.
- The 53rd Annual Medical Student Research Day at the Whiddon College of Medicine will take place on Friday, July 24, 2026, showcasing summer research from 69 medical students. - The eight-week summer research program included 58 rising M2 students and 11 incoming M1 students conducting basic, clinical, and translational research alongside faculty mentors. - Julie A. Bastarache, M.D., from Vanderbilt University Medical Center will deliver the keynote lecture titled "A Series of (Un)fortunate Events: My Journey from Fellow to Tenure." - Winners of the Clyde G. "Sid" Huggins Medical Student Research Awards, honoring the college's first dean of students, will be announced following the poster sessions.
- The University of South Alabama's Whiddon College of Medicine awarded its 2026 Dean's Predoctoral Fellowship to three Basic Medical Sciences graduate students: Brusi Kola, Sarah Macon-Foley, and Brianna Mitchell. - Brusi Kola is investigating neurotensin-mediated crosstalk between adipocytes and lymphatic endothelial cells in breast cancer metastasis, a process implicated in the majority of breast cancer-related deaths. - Brianna Mitchell is characterizing macrophage-driven cytokine release during initial anti-CD20 monoclonal antibody therapy to understand cytokine release syndrome and improve treatment safety. - The one-year fellowship provides each recipient a stipend, individual health insurance, and $5,000 for conference travel and extramural training.
- Inflammatix published three landmark studies in Nature Medicine that redefine sepsis diagnosis and treatment through AI-powered immune profiling and consensus frameworks. - The SEPSIS-SHIELD study validated TriVerity's ability to distinguish bacterial from viral infections and predict illness severity in over 1,200 patients with high sensitivity and specificity. - Two new consensus frameworks, HI-DEF and CTS, identified distinct immunological states in sepsis patients, with dysregulated patients showing 5-7 times higher mortality risk. - TriVerity received FDA 510(k) clearance in January 2025 and delivers results in 30 minutes to guide emergency department triage decisions.
